Worrying about medication costs is a heavy burden for millions of Americans.
This GivingTuesday (12/2), your gift can help HealthWell lift the financial burden of critical medical treatments for underinsured Americans.
Chronic Obstructive Pulmonary Disease - Medicare Access (Medicare patients only)
Status
ClosedThis fund is temporarily closed to new patients due to lack of sufficient funding. Please continue to visit our Disease Funds page often, as replenished funds reopen as quickly as possible. If you currently have a grant with HealthWell, your grant will remain active for the entire 12 month grant cycle or until you have exhausted your allocated grant amount, whichever comes first. You can continue to use your pharmacy card or submit requests for reimbursements during your designated grant cycle.
Assistance Type
Prescription Drug Copayor
Insurance premium (Medicare Part B only)
Maximum Award Level
Payment Type
Pharmacy CardMinimum Copay Reimbursement Amount
We encourage you to please use your HealthWell pharmacy card for any applicable charges as possible.
Minimum Premium Reimbursement Amount
Household Income Limit
500% of the Federal Poverty Level(adjusted for household size and high cost of living areas)
Treatments Covered
- Acetadote
- Acetylcysteine
- Aclidinium Bromide
- Aclidinium Bromide And Formoterol Fumarate
- Adoxa
- Advair Diskus
- Airduo Respiclick
- Albuterol Sulfate
- Alkindi Sprinkle
- Aminophylline
- Amoxicillin
- Amoxicillin And Clavulanic Acid
- Ampicillin
- Ampicillin Sodium
- Ampicillin Sodium And Sulbactam Sodium
- Anoro Ellipta
- Arformoterol Tartate
- Arunity Ellipta
- Arymo Er
- Atrovent Hfa
- Augmentin
- Avelox
- Avidoxy
- Azithromycin
- Bactrim
- Bactrim Ds
- Beclomethasone Dipropionate
- Bevespi Aerosphere
- Breo Ellipta
- Breyna
- Breztri Aerosphere
- Brovana
- Budesonide
- Budesonide And Formoterol
- Budesonide And Glycopyrrolate And Formoterol
- Cefdinir
- Cefepime
- Cefixime
- Cefotaxime
- Cefpodoxime Proxetil
- Cefprozil
- Ceftriaxone Sodium
- Cefuroxime Axetil
- Cipro
- Ciprofloxacin
- Clarithromycin
- Colistimethate
- Coly-mycin M Parenteral
- Combivent Respimat
- Cortef
- Daliresp
- Decadron
- Dex24
- Dexabliss 11-day Dose Pack
- Dexamethasone
- Dexamethasone Intensol
- Dexamethasone Sodium Phosphate
- Dopram
- Doryx
- Doxapram Hydrochloride
- Doxy 100
- Doxycycline
- Doxycycline Calcium
- Doxycycline Hyclate
- Duaklir Pressair
- Dulera
- Dupilumab
- Dupixent Pen
- Duramorph
- Dxevo
- Elixophyllin
- Ensifentrine
- Ery-tab
- Erythromycin
- Fluticasone Furoate
- Fluticasone Furoate And Vilanterol Trifenatate
- Fluticasone Furoate And Vilanterol Trifenatate And Umeclidinium
- Fluticasone Propionate And Salmeterol Xinafoate
- Formoterol Fumarate
- Formoterol Fumarate And Mometasone Furoate
- Glycopyrrolate
- Glycopyrrolate And Formoterol Fumurate
- Hemady
- Hidex
- Hydrocortisone
- Hydrocortisone Sodium Succinate
- Incruse Ellipta
- Infumorph 500
- Ipratropium Bromide
- Ipratropium Bromide And Albuterol Sulfate
- Isoproterenol Hydrochloride
- Kadian
- Levalbuterol Hcl
- Levalbuterol Tartrate
- Levofloxacin
- Lymepak
- Magnesium Sulfate
- Medrol
- Mepolizumab
- Metaproterenol Sulfate
- Methylprednisolone
- Methylprednisolone Sodium Succinate
- Millipred
- Mitigo
- Morgidox
- Morphine Sulfate
- Moxatag
- Moxifloxacin Hydrochloride
- Ms Contin
- N-acetyl-l-cysteine
- Nucala
- Ohtuvayre
- Olodaterol Hydrochloride
- Oracea
- Orapred Odt
- Pediapred
- Perforomist
- Prednisolone
- Prednisolone Sodium Phosphate
- Prednisone
- Prednisone Intensol
- Proair Digihaler
- Proair Respiclick
- Proventil Hfa
- Pulmicort Flexhaler
- Pulmicort Respules
- Qnasl
- Qvar Redihaler
- Rayos
- Revefenacin
- Roflumilast
- Salmeterol Xinafoate
- Serevent Diskus
- Solu-cortef
- Solu-medrol
- Spiriva Handihaler
- Spiriva Respimat
- Stiolto Respimat
- Striverdi Respimat
- Sulfamethoxazole And Trimethoprim
- Suprax
- Symbicort
- Taperdex
- Targadox
- Terbutaline Sulfate
- Theo-24
- Theophylline
- Tiotropium Bromide
- Tiotropium Bromide And Olodaterol
- Trelegy Ellipta
- Tudorza Pressair
- Umeclidinium
- Umeclidinium Bromide And Vilanterol Trifenatate
- Unasyn
- Ventolin Hfa
- Veripred 20
- Vibramycin Calcium
- Vibramycin Hyclate
- Vibramycin Monohydrate
- Wixela Inhub
- Xopenex Hfa
- Yupelri
- Z-cort 7-day
- Zithromax
Fund Definition
Assistance with the prescription drugs and biologics used in the treatment of chronic obstructive pulmonary disease.
Grant Utilization
As a result of the impact of the Inflation Reduction Act on Medicare Part D maximum out of pocket, average grant utilization calculation for Medicare Access Funds are based on forecasted utilization. The forecasted average grant utilization for this disease fund is: $1,500Do I Qualify?
HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:
-
Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.
-
This is a Medicare Access Fund. In order to qualify for premium assistance through this fund, you must have Medicare Part B. The Foundation will refer patients without Medicare to other programs, such as manufacturer patient assistance programs.
-
HealthWell assists individuals with incomes up to 300-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
-
If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.
About Chronic Obstructive Pulmonary Disease
COPD describes chronic lung diseases including emphysema (damage to the air sacs) and chronic bronchitis (damage to the bronchial tubes), which are characterized by breathlessness. COPD can progress for years without noticeable shortness of breath. Symptoms of COPD include increased shortness of breath, frequent coughing, wheezing, tightness in the chest, and unusual tiredness. Currently, COPD is an incurable disease, but treatments are available to help patients breathe better and improve their quality of life. COPD affects an estimated 30 million Americans, many of whom are undiagnosed.
Additional Educational Resources
You may also visit our Resource List to view other copayment organizations that may provide assistance.